We cannot exclude the possibility that these discrepancies are due to additional factors that are present in the T2DM patients such as insulin levels, dyslipidemia and metabolic changes, medication, but they cannot be recapitulated in the in vitro system under high‐glucose conditions. Here, INS is linked to metabolic syndrome.